Tokyo Tape
Sign in
← Ain Holdings

Quarterly report · Q2

9627.TEDINET S100PT4M
Period2022-05-01 → 2022-10-31
Filed2022-12-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥171.2bn2022-05-01 → 2022-10-31Cons.Net sales
Revenue¥316.2bn2021-05-01 → 2022-04-30Cons.Net sales (5-year summary)
Revenue¥153.0bn2021-05-01 → 2021-10-31Cons.Net sales
Operating income¥6.8bn2022-05-01 → 2022-10-31Cons.Operating income
Operating income¥5.8bn2021-05-01 → 2021-10-31Cons.Operating income
Ordinary income¥7.3bn2022-05-01 → 2022-10-31Cons.Ordinary income
Ordinary income¥16.0bn2021-05-01 → 2022-04-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥6.1bn2021-05-01 → 2021-10-31Cons.Ordinary income
Profit before tax¥7.2bn2022-05-01 → 2022-10-31Cons.Income before income taxes
Profit before tax¥6.1bn2021-05-01 → 2021-10-31Cons.Income before income taxes
Net income (owners)¥3.8bn2022-05-01 → 2022-10-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥7.1bn2021-05-01 → 2022-04-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.3bn2021-05-01 → 2021-10-31Cons.Profit loss attributable to owners of parent
Net income¥3.8bn2022-05-01 → 2022-10-31Cons.Profit loss
Net income¥3.3bn2021-05-01 → 2021-10-31Cons.Profit loss
Total assets¥231.1bnat 2022-10-31Cons.Assets
Total assets¥212.5bnat 2022-04-30Cons.Assets
Total assets¥210.4bnat 2021-10-31Cons.Total assets (5-year summary)
Total liabilities¥110.3bnat 2022-10-31Cons.Liabilities
Total liabilities¥93.5bnat 2022-04-30Cons.Liabilities
Net assets / equity¥120.9bnat 2022-10-31Cons.Net assets
Net assets / equity¥119.0bnat 2022-04-30Cons.Net assets
Net assets / equity¥115.8bnat 2021-10-31Cons.Net assets (5-year summary)
Cash and deposits¥46.7bnat 2022-10-31Cons.Cash and deposits
Cash and deposits¥59.7bnat 2022-04-30Cons.Cash and deposits
Cash & equivalents¥43.5bnat 2022-10-31Cons.Cash and cash equivalents
Cash & equivalents¥59.5bnat 2022-04-30Cons.Cash and cash equivalents
Cash & equivalents¥58.4bnat 2021-10-31Cons.Cash and cash equivalents
Cash & equivalents¥55.0bnat 2021-04-30dCons.Cash and cash equivalents
Operating cash flow¥8.5bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in operating activities
Operating cash flow¥26.2bn2021-05-01 → 2022-04-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥17.3bn2021-05-01 → 2021-10-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥18.6bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥13.9bn2021-05-01 → 2022-04-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥8.3bn2021-05-01 → 2021-10-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥5.8bn2022-05-01 → 2022-10-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥7.8bn2021-05-01 → 2022-04-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥5.6bn2021-05-01 → 2021-10-31Cons.Net cash provided by used in financing activities
EPS (basic)¥108.32022-05-01 → 2022-10-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.772022-08-01 → 2022-10-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥201.472021-05-01 → 2022-04-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥94.682021-05-01 → 2021-10-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥57.62021-08-01 → 2021-10-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio52.3%at 2022-10-31Cons.Equity to asset ratio (5-year summary)
Equity ratio56.0%at 2022-04-30Cons.Equity to asset ratio (5-year summary)
Equity ratio55.0%at 2021-10-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Otherother segmentsrevenue2022-05-01 → 2022-10-31¥5.8bn
Otherother segmentsrevenue external2022-05-01 → 2022-10-31¥5.8bn
Otherother segmentsrevenue intersegment2022-05-01 → 2022-10-31¥31m
Otherother segmentssegment ordinary income2022-05-01 → 2022-10-31−¥18m
Reconciling Itemsreconcilingrevenue2022-05-01 → 2022-10-31−¥31m
Reconciling Itemsreconcilingrevenue intersegment2022-05-01 → 2022-10-31−¥31m
Reconciling Itemsreconcilingsegment ordinary income2022-05-01 → 2022-10-31−¥3.8bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue2022-05-01 → 2022-10-31¥153.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2022-05-01 → 2022-10-31¥153.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2022-05-01 → 2022-10-31¥10.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2022-05-01 → 2022-10-31¥12.2bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2022-05-01 → 2022-10-31¥12.2bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2022-05-01 → 2022-10-31¥349m
—segment totalrevenue2022-05-01 → 2022-10-31¥171.2bn
—segment totalrevenue external2022-05-01 → 2022-10-31¥171.2bn
—segment totalrevenue intersegment2022-05-01 → 2022-10-31¥31m
—segment totalsegment ordinary income2022-05-01 → 2022-10-31¥11.1bn
Otherother segmentsrevenue2021-05-01 → 2021-10-31¥6.3bn
Otherother segmentsrevenue external2021-05-01 → 2021-10-31¥6.3bn
Otherother segmentsrevenue intersegment2021-05-01 → 2021-10-31¥47m
Otherother segmentssegment ordinary income2021-05-01 → 2021-10-31−¥121m
Reconciling Itemsreconcilingrevenue2021-05-01 → 2021-10-31−¥47m
Reconciling Itemsreconcilingrevenue intersegment2021-05-01 → 2021-10-31−¥47m
Reconciling Itemsreconcilingsegment ordinary income2021-05-01 → 2021-10-31−¥3.1bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue2021-05-01 → 2021-10-31¥136.9bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2021-05-01 → 2021-10-31¥136.9bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2021-05-01 → 2021-10-31¥10.5bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2021-05-01 → 2021-10-31¥9.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2021-05-01 → 2021-10-31¥9.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2021-05-01 → 2021-10-31−¥1.1bn
—segment totalrevenue2021-05-01 → 2021-10-31¥153.0bn
—segment totalrevenue external2021-05-01 → 2021-10-31¥153.0bn
—segment totalrevenue intersegment2021-05-01 → 2021-10-31¥47m
—segment totalsegment ordinary income2021-05-01 → 2021-10-31¥9.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 565
ItemContextValueUnit
Income taxesPrior1YTDDuration2736000000JPY
Income taxesCurrentYTDDuration3368000000JPY
Profit lossPrior1YTDDuration3328000000JPY
Profit lossCurrentYTDDuration3796000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-10000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-8000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration3338000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration3804000000JPY
Profit lossPrior1YTDDuration3328000000JPY
Profit lossCurrentYTDDuration3796000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-37000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-39000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration20000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration12000000JPY
Other comprehensive incomePrior1YTDDuration-16000000JPY
Other comprehensive incomeCurrentYTDDuration-26000000JPY
Comprehensive incomePrior1YTDDuration3311000000JPY
Comprehensive incomeCurrentYTDDuration3769000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration3321000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration3777000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-10000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-8000000JPY
Income before income taxesPrior1YTDDuration6064000000JPY
Income before income taxesCurrentYTDDuration7165000000JPY
Depreciation and amortization ope cfPrior1YTDDuration2117000000JPY
Depreciation and amortization ope cfCurrentYTDDuration2567000000JPY
Share based compensation expenses ope cfPrior1YTDDuration－JPY
Share based compensation expenses ope cfCurrentYTDDuration21000000JPY
Amortization of goodwill ope cfPrior1YTDDuration2055000000JPY
Amortization of goodwill ope cfCurrentYTDDuration2115000000JPY
Impairment loss ope cfPrior1YTDDuration6000000JPY
Impairment loss ope cfCurrentYTDDuration63000000JPY
Loss gain on step acquisitions ope cfPrior1YTDDuration-131000000JPY
Loss gain on step acquisitions ope cfCurrentYTDDuration－JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration3000000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration-9000000JPY
Increase decrease in contract liabilities ope cfPrior1YTDDuration65000000JPY
Increase decrease in contract liabilities ope cfCurrentYTDDuration53000000JPY
Increase decrease in net defined benefit liability ope cfPrior1YTDDuration193000000JPY
Increase decrease in net defined benefit liability ope cfCurrentYTDDuration-606000000JPY
Loss gain on transfer of business ope cfPrior1YTDDuration-5000000JPY
Loss gain on transfer of business ope cfCurrentYTDDuration-46000000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration859000000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration676000000JPY
Increase decrease in provision for directors bonuses ope cfPrior1YTDDuration6000000JPY
Increase decrease in provision for directors bonuses ope cfCurrentYTDDuration12000000JPY
Interest and dividends income ope cfPrior1YTDDuration-43000000JPY
Interest and dividends income ope cfCurrentYTDDuration-55000000JPY
Interest expenses ope cfPrior1YTDDuration22000000JPY
Interest expenses ope cfCurrentYTDDuration27000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-04-30pass rounding
balance sheet identityconsolidated 2022-10-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-04-30pass
statement vs summary · net assetsconsolidated 2022-10-31pass
statement vs summary · net income attributable to parentconsolidated 2021-05-01/2021-10-31pass
statement vs summary · net income attributable to parentconsolidated 2022-05-01/2022-10-31pass
statement vs summary · operating cash flowconsolidated 2021-05-01/2021-10-31pass
statement vs summary · operating cash flowconsolidated 2022-05-01/2022-10-31pass
statement vs summary · revenueconsolidated 2021-05-01/2021-10-31pass
statement vs summary · revenueconsolidated 2022-05-01/2022-10-31pass
statement vs summary · total assetsconsolidated 2022-04-30pass
statement vs summary · total assetsconsolidated 2022-10-31pass